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Abstract 
  
In this study we investigated the possibility of using layer-by-layer deposition, based in 
natural polymers (chitosan and alginate), to control the release of different ophthalmic 
drugs from three types of lens materials: a silicone-based hydrogel recently proposed by 
our group as drug releasing soft contact lens (SCL) material and two, commercially 
available, intraocular lens (IOL) materials (CI26Y and Definitive 50). The optimised 
coating, consisting in one double layer of (alginate - CaCl2) / (chitosan+glyoxal) topped 
with a final alginate-CaCl2 layer to avoid chitosan degradation by tear fluid proteins, 
proved to have excellent features to control the release of the anti-inflammatory, 
diclofenac, while keeping or improving the physical properties of the lenses. The 
coating leads to a controlled release of diclofenac from SCL material- for one week and, 
up to 120 h, for IOL materials. Due to its high hydrophilicity (water contact angle ≈ 0) 
and biocompatibility, it should avoid the use of further surface treatments to enhance 
the user´s comfort. However, the barrier effect of this coating is specific for diclofenac, 
giving evidence to the need of optimizing the chemical composition of the layers in 
view of the desired drug.  
 
Key words: Controlled drug release; Ophthalmic lens; Layer-by-layer coatings; 
Alginate; Chitosan. 
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1. Introduction 
 
The development of therapeutic ophthalmic lenses which ensure extended release of 
suitable drugs has been faced as a solution to avoid the tedious and inefficient eye drop 
administration. The efforts made by many researchers in the last decades to optimize 
drug delivery through soft contact lenses (SCLs) have been described in several recent 
reviews [1–3]. In the case of cataracts which are, nowadays, one of the most frequent 
eye diseases, other devices have been investigated to prevent postoperative infectious 
complications after surgery, namely, therapeutic intraocular lenses (IOLs) [4–6]. 
One of the main problems in the implementation of drug-loaded ophthalmic lenses to 
substitute the topical application of eye drops is the control of the drug release. In fact, 
the drug release from these devices is usually characterized by an initial burst which 
may be followed by decreasing the released drug to levels under therapeutic range, in 
the subsequent hours. Several approaches have been undertaken to ensure a continuous 
delivery of medication to the eye, during the required period, and at a controlled rate: 
(1) incorporation of chemical agents that can interact reversibly with the drug [7]; (2) 
the use of nanocarriers, such as micelles, liposomes or nanoparticles [8,9]; (3) 
introduction of diffusion barriers to the drugs, such as Vitamin E aggregates [10,11].  
One possibility that, to our knowledge, has not been much investigated is the 
application of coatings which could be used in commercial lenses whose properties and 
production are already optimized. Coatings are presently applied to commercial SCLs to 
improve the surface wettability and lubricity, leading, as a result, to an increased 
comfort to the user. Other objective of this type of coatings is to avoid the adsorption of 
microorganisms and proteins from the ocular tear fluid which is one of the main causes 
of eye infections among the contact lenses users. The coatings applied to SCLs are, 
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essentially, based on polyelectrolyte multilayers obtained using layer-by-layer (LbL) 
deposition [12], on the adsorption/grafting of specific molecules [13,14], and on the 
immobilization of liposomes at the surface of the lens [15]. The LbL technique has been 
attracting great attention because it allows a high level of control over the composition 
and the physical properties of the coating material. It consists on the formation of a 
polyelectrolyte multilayer through the consecutive adsorption of polycation-polyanion 
layers by electrostatic interactions. The first LbL polyelectrolyte complexes were based 
on strong polyelectrolytes  [16], but later, research attention shifted to multilayers of 
weak polyelectrolytes, e.g. poly(acrylic acid) (PAA) and poly(allylamine hydrochloride) 
(PAH) [17], which afford greater control of the properties of the LbL coatings. The use 
of LbL coatings to control drug release usually relies on specific interactions between 
the polyelectrolytes and the drugs loaded in the nanolayers which are weakened by 
structural changes of the coatings resulting from external stimuli, such as changes of 
pH, ionic strength, solvent, and applied external energy [18–20]. LbLs have also been 
used to build the shells of hollow capsules where solutes may be encapsulated and then 
released across the membrane in the presence of a concentration gradient [21,22]. 
Recently, the natural polymers alginate and chitosan have been under the attention of 
researchers in the field of LbL applications. Owing to the biocompatibility, non-
antigenicity and non- toxicity of these biopolymers, they have been considered as an 
excellent choice for applications in drug delivery systems [23–26] and tissue 
engineering scaffolds [27, 28]. Chitosan is a cationic copolymer of β-(1-4)-linked 2-
acetamido-2-deoxy-d-glucopyranase and 1-amino-2-deoxy-d-glucopyranase. Due to its 
physicochemical characteristics, namely permeation enhancing properties, chitosan is an 
adequate material for drug delivery ocular devices [29]; however, it has very low 
mechanical integrity and enzymatically degrades, e.g, by the action of lysozyme [30]. 
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Alginate is an anionic linear polysaccharide containing -(1,4)-linked d-mannuronic acid 
and l-glucuronic acid residues which has the advantage of forming ionically crosslinked 
hydrogels [31]. 
The objective of the present work is to assess the performance of LbL coatings based in 
chitosan-alginate multilayers to control the drug release from hydrogels used as lens 
materials: 1) one silicone (3-tris(trimethylsilyloxy)silylpropyl 2-methylprop-2-enoate 
designated by TRIS)- based hydrogel which was recently investigated as drug releasing 
SCL material [32]; 2) two IOL materials commercially available under the names of 
CI26Y and Definitive 50 from Contamac Products (U.K.). CI26Y is a hydrophilic 
material composed by 2-hydroxyethyl methacrylate (HEMA) and methylmethacrylate 
(MMA), while Definitive 50 is a blend of fluorosilicone and hydrophilic monomers. 
CI26Y and Definitive 50 have water contents of 26% and 50%, respectively, while that 
of TRIS-based hydrogel is 41%.   
Four drugs were tested using the TRIS-based hydrogel: an antibiotic, moxifloxacin, an 
antiseptic, chlorhexidine, and two anti-inflammatories, diclofenac and ketorolac. 
Moxifloxacin is a fourth-generation synthetic fluoroquinolone antibiotic commonly 
used in the treatment of treatment of conjunctivitis, keratitis, keratoconjunctivitis, and 
bacterial endophthalmitis [33,34]. This molecule has a lipophilic character and its 
protonated form predominates in water at pH 5.6 [35]. Chlorhexidine is a hydrophilic, 
cationic drug with antibacterial properties which has long been known as a first line 
treatment for Acanthamoeba keratitis [36,37]. Diclofenac and ketorolac are non-
steroidal, anti-inflammatory drugs which are mainly used to treat inflammation and to 
control pain in the postoperative period.  Both are anionic and soluble in water as salts 
but, in their acidic form, they are hydrophobic drugs [38,39]. Diclofenac was further 
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tested in CI26Y and Definite 50. The characteristics of the drugs, in terms of structure, 
lyophilicity, ionicity and molecular weight (MW), are summarized in Table 1. 
 
Table 1 - Characteristics of the studied drugs. 
 
Drug 
 
Structure Lyophilicity Ionicity Mw (g/mol) 
Moxifloxacin 
hydrochloride 
 
Lipophilic Zwitterionic  401.43 
Chlorhexidine 
diacetate  
Hydrophilic Cationic 643.57 
Ketorolac tris 
salt 
 
Hydrophilic Anionic 376.4 
Diclofenac 
sodium salt 
 
Hydrophilic Anionic 318.13 
 
The formation of the chitosan/alginate layers was followed using a quartz crystal 
microbalance with dissipation and the topography, wettability and thickness of the LbL 
coatings were assessed. The effects of the coating on the transmittance and the 
refractive index of the samples were evaluated. Alterations in the drug release profiles 
induced by the LbL coating were studied.  
Although LbL coatings based on chitosan and alginate have already been used to 
improve the surface properties of materials required for ophthalmic applications, they 
were never applied, to our knowledge, as a barrier to the drug diffusion. The novelty of 
this investigation is the successful application of an optimized chitosan/alginate LbL 
coating to combine a sustained drug release with adequate surface properties. 
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2. Materials and Methods 
 
2.1 Materials 
3-Tris(trimethylsilyloxy)silylpropyl 2-methylprop-2-enoate, 98% (TRIS), 2-
hydroxyethyl methacrylate, ≥99% (HEMA), ethylene glycol dimethacrylate, 98% 
(EDGMA), 2,20-azobis isobutyronitrile, 98% (AIBN), acetic acid, ≥99.7%, alginic acid 
sodium salt from brown algae (alginate sodium) with mean molecular weight of  100-
200 KDa, diclofenac sodium salt, ketorolac tris salt, ≥99%, glyoxal solution 40 % (w/w) 
in H2O, polyethylenimine (PEI) with mean molecular weight of 750 KDa,  were 
provided by Sigma–Aldrich. Chlorhexidine diacetate monohydrate, 98%, was supplied 
by AppliChem. N-Vinyl pyrrolidone, 98% (NVP), and sodium hydroxide, 99% 
(NaOH), were obtained from Merck. Sodium chloride, 99% (NaCl), sulfuric acid, 98% 
(H2SO4), and hydrogen peroxide, (H2O2), 30% (w/v), were purchased from Panreac. 
Moxifloxacin hydrochloride was purchased from Carbosynth and Hellmanex®II, from 
Hellma GmbH. Medical grade chitosan (high degree of acetylation), >90%, with mean 
molecular weight of 750 -1000 kDa, was supplied by Altakitin (Portugal), CI26Y and 
Definitive 50 (Contamac UK) were supplied by Physiol (Belgium). CI26Y contains a 
blue-light blocker which is proprietary to Physiol (patent WO2006074843; Yellow 
Chromophore Agent Composition for Intraocular Lenses and the thus Obtained Lenses). 
Polystyrene (PS) was synthesized and offered by Dra Clara Gomes from CQE-IST 
(Portugal). Lysozyme chicken egg white is from CalbioChem. Distilled and deionised 
(DD) water obtained from a Millipore system was used to prepare all solutions. 
 
2.2 Preparation of polymeric samples 
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The silicone-based hydrogel (TRIS/NVP/HEMA) was synthesized, according to the 
procedure described elsewhere [40]. A mixture of 0.8 M of TRIS, 3.9 M of NVP, 1.8 M 
of HEMA, and 30 mM of EGDMA was prepared and degassed by ultrasounds (5 min) 
and bubbling with nitrogen (10 min). Then, AIBN was added to get a concentration of 
15 mM, and the solution was homogenised by magnetic stirring. The final solution was 
poured into a mould constituted by two silanized glass plates separated by a Teflon 
frame with 0.3 mm of thickness.  The silanization process reported in [41] was 
followed.  Polymerization was done in an oven at 60°C for 24 h. In order to remove 
unreacted monomers and other impurities, the polymerized hydrogel was washed with 
DD water for 5 days, with renovation two times a day. Finally, the hydrated hydrogel 
sheets (thickness ≈ 300 µm) were cut in disks with 9 mm of diameter.  
CI26Y and Definitive 50 samples were washed in a soxhlet extractor with DD water, for 
60 cycles, according to the recommendations of the supplier and cut in disks with 
average thickness ≈ 1 mm and diameter of 6 mm. All samples were dried overnight in 
an oven at 36°C and stored inside closed flasks.  
 
2.3 Drug loading and drug release tests 
TRIS/NVP/HEMA dry samples (average weight 21 mg) were loaded with the drugs by 
soaking in 3 mL of drug solution with a concentration of 1 mg/mL for diclofenac and 
ketorolac, 2.5 mg/mL for chlorohexidine and 5 mg/mL for moxifloxacin. The loadings 
were done at 4°C for 38 h in the former two cases, and 72 h in the latter cases. The 
drugs were dissolved in a 130 mM NaCl solution, except chlorhexidine which was 
dissolved in DD water. The CI26Y (average weight 19.4 mg) and Definitive 50 
(average weight mg) samples were loaded with diclofenac using the same conditions. 
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The release measurements were done by soaking the samples in a 3 mL saline solution 
(130 mM), at 36°C, with a 150 rpm stirring. Volumes of 200 µL were removed at 
scheduled times to measure the drug concentration, being replaced by the same volumes 
of new saline solution.  
The concentration of the drugs in the collected solutions was determined by measuring 
the absorbance with a UV-Vis spectrophotometer (Multiskan GO, Thermo Scientific) at 
a wavelength of 255 nm for chlorohexidine, 276 nm for diclofenac, 290 nm for 
moxifloxacin and 323 nm for ketorolac. 
 
2.4 LbL deposition 
The drug loaded hydrogels were first coated with PEI which covalently bounds to the 
hydroxyl groups existing on their surface [42], by soaking the samples for 5 min in a 
PEI aqueous solution (20 mM). Meanwhile, the alginate and chitosan solutions with 
concentration of 10 mM each were prepared in DD water and in aqueous solution of 
acid acetic 1% (v/v), respectively. The pH of the alginate and chitosan solutions was 6.5 
and 3.0, respectively. The pH of the chitosan solution was then adjusted to 5.0, with 
NaOH, in order to maintain its positive charge while avoiding depolymerisation of 
chitosan [43]. In some referred cases, 5% (w/w) of glyoxal solution (GL) was added to 
the chitosan solution. One double layer was achieved by dipping the hydrogel samples 
into the alginate solution for 1 min, subsequently immersing in 1 M CaCl2 solution for 3 
min, and finishing with chitosan solution for 1 min. To protect the chitosan layer from 
being enzymatically degraded by lysozyme [30,44], a final layer of alginate (crosslinked 
with CaCl2) was deposited. After immersion in each solution, a rinsing with DD water 
was done. In the case of samples produced with chitosan solutions containing glyoxal, 
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the crosslinking of chitosan was achieved by drying the samples in the oven at 45ºC 
during 1 h, in the final stage.  
In the meantime, drug loaded samples without coating (blank samples) were immersed 
in DD water during the time of the LbL formation (≈15 min) to mimic the process 
undergone by the coated samples. The blank samples prepared for comparison with 
those coated using glyoxal were finally placed inside an oven at 45°C for 1 h. With this 
procedure, it was ensured that the amount of drug lost during the LbL formation, which 
was experimentally determined through the analysis of the respective immersion 
solutions, was also lost by the blank samples.  
The prepared samples were then immediately used for the drug release tests.  
 
2.5 Evaluation of the LbL stability 
The formation of the layers was studied using a quartz crystal microbalance with 
dissipation (QCM-D, E4 from Q-Sense). As previous described [40], the sensors were 
gold coated quartz crystals (5 MHz), which were previously covered with a polystyrene 
(PS) film by spin coating (2000 rpm, 30 s), and then coated with the 
(TRIS/NVP/HEMA) hydrogel forming reactional mixture (described in 2.2.) by spin 
coating (5000 rpm, 30 s).The hydrogel films were thermopolymerized at 60°C for 1 h. 
A nitrogen atmosphere was used for both deposition and polymerization steps to avoid 
the presence of oxygen which inhibits the crosslinking [45].  
The experimental baseline was obtained with the hydrogel films pre-hydrated in DD 
water. Normalized frequency (∆f/n) and dissipation (∆D) changes (where n = 1, 3, 5, 7, 
9, and 11 corresponds to the number of the overtone of the fundamental frequency, 5 
MHz) were monitored during the process of LbL deposition. After the addition of each 
solution a rinsing step was done with DD water. 
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The eventual degradation effect of the lysozyme on the LbL coating was studied by 
adding lysozyme solution after the stabilization of layers, followed by rinsing with NaCl 
solution. The concentration of lysozyme solution was 1.9 mg/mL to simulate that of the 
lacrimal fluid [46–48]. Eight independent experiments were made at 36°C. 
After each experiment, the quartz crystals were cleaned by dipping for 5 s in piranha 
solution: H2SO4/H2O2 7/3 v:v (Caution: Piranha solution is highly corrosive and reacts 
violently with organic matter). Immediately afterwards, the crystals were washed in 
ultrasounds with a 2% (v/v) Hellmanex solution (15 min), followed by water (2x15 
min). Then, they were rinsed with DD water, dried with a nitrogen flux and stored 
inside closed flasks. 
  
2.6 Topography 
Topographic images of the surfaces of the hydrated hydrogels were obtained using an 
atomic force microscope (AFM) Nanosurf EasyScan 2. The analyses were done in 
tapping mode, at room temperature. Images of 20x20 µm2 were obtained with silicon 
probes (resonance frequency: 204 – 497 kHz) at a scan rate of 0.7 Hz. The average 
roughness (Ra) of the surfaces was obtained for the total area of the images, using the 
software WSxM 5.0 develop 8.0. 
 
2.7 Wettability 
The wettability of the dry hydrogels was determined using the sessile drop method. The 
samples were previously dried for 72 h inside a vacuum oven, at room temperature. 
Drops of DD water were deposited with a micrometric syringe and on the substrate 
surface inside a temperature controlled chamber model 100-07-00 (Ramé-Hart, NJ, 
USA).The hydrated hydrogels were characterized by measuring the contact angles of 
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captive air bubbles lying underneath the substrates immersed in water. The images of 
drops and bubbles were obtained through a video camera (jAi CV-A50, Spain) mounted 
on a microscope Wild M3Z (Leica Microsystems, Germany) and analyzed by running 
the ADSA (Axisymmetric Drop Shape Analysis, Applied Surface Thermodynamics 
Research Associates, Toronto, Canada) software.  
 
2.8 Optical properties 
The transmittance of the hydrated hydrogel samples was determined with a UV-Vis 
spectrophotometer (Multiskan GO, Thermo Scientific). The wavelength interval of 400 
to 700 nm was scanned with 1 nm intervals.  
Ellipsometric functions tan Ψ and cos ∆ were measured in the spectral range from 300 – 
850 nm using a phase modulated spectroscopic ellipsometer (UVISEL, Horiba Jobin–
Yvon), at 70o incidence angle. The thickness and refractive index of the films/hydrogels 
were determined through suitable modelling using the DeltaPsi2 software package from 
Jobin-Yvon with a Cauchy dispersion function. 
 
3. Results and discussion 
 
3.1 Optimization of the LbL coating 
The formation of the layers during the LbL deposition process was followed by QCM-
D. The time course of ∆f/n and ∆D upon contact of the TRIS/NVP/HEMA hydrogel-
coated quartz crystals with the polyelectrolyte solutions is shown in Figure 1.  
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Figure 1 
 The baseline corresponds to the coated sensors equilibrated with water. After injection 
of the PEI solution, alginate, CaCl2 and chitosan solutions were sequentially introduced, 
terminating with a second injection of alginate and CaCl2 .The observed frequency and 
dissipation shifts indicate the formation of stable layers, where the rinsing steps 
performed after each injection had a small effect, demonstrating that the layers 
remained irreversibly adsorbed on the surface. The resistance of this coating terminated 
with a final layer of alginate and CaCl2 against lysozyme was confirmed from the 
observation that the injection of the protein solution did not induce any change in the 
frequency and dissipation of the adsorbed layers for several hours (> 4 h). At this point, 
it is important to refer that the toxicity of PEI should not be a problem because it was 
used as the deepest layer which remained attached to the surface. Moreover, there are 
several reports in the literature about the reduction of the cytotoxicity of PEI in presence 
of chitosan and alginate [49,50]. However, cytocompatibility tests would be necessary 
before in vivo application. 
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In order to test the effect of the number of layers, 1, 2 and 4 (alginate-CaCl2)/chitosan 
double layers were deposited on top of the TRIS/NVP/HEMA surface always 
terminated by an alginate-CaCl2 layer. The cumulative release profiles of diclofenac 
from TRIS/NVP/HEMA hydrogels are presented in Figure 2.  
 
 
Figure 2 
Analysis of the figure shows that deposition of 1 and 2 double layers decreases the 
initial rate of drug release and extends the release duration, thus, significantly 
improving the release profile. However, 4 double layers almost hinder the release of the 
drug which led us to abandon this number of layers. Then, the wettability, roughness, 
transmittance and coating thickness of the hydrogels with 0, 1 and 2 double layers were 
determined and the measured values are presented in Table 2 (three first columns). The 
thickness of 1 double layer could not be measured apparently due to the heterogeneous 
nature of this coating. The contact angles of water on the hydrated sample (captive 
bubble) with 1 double layer and the dried samples (sessile drop) with 1 and 2 double 
layers were not measured. 
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Table 2- Properties of uncoated and coated TRIS/NVP/HEMA hydrogels: water contact 
angles on hydrated and dried samples, average roughness (Ra), transmittance, coating 
thickness, and refraction index.  The errors are standard deviations (in all cases n=3, 
except the contact angles with n=10). 
 
Uncoated 
samples 
1 Double 
layer 
2 Double 
layers 
1 Double layer 
with glyoxal 
Contact angle (°) 
(captive bubble) 
 
35±5 - 42±2 ≈ 0 
Contact angle (°) 
(sessile drop) 
 
83±6 - - 27±5 
Average roughness, 
(nm) 
 
20±9 26±7 16±8 33±2 
Transmittance (%) 98±0.5 92±1 80±1 94±2 
Thickness (nm) - - 60±3 40±1 
Refraction index 1.46±0.02 1.41±0.02 1.48±0.01 1.50±0.01 
 
The roughness increased after the first double layer but then decreased when the second 
double layer was introduced; the refraction index lowered with the first double layer, 
but recovered for the second one, which may be attributed to different contents of water 
in these samples. The wettability of the hydrated sample with the 2 double layers 
coating slightly decreased.  
The AFM images showing the topography of the samples are presented in Figure 3 a), 
b) and c). The porous structure, which is typical of these hydrogels and has already been 
reported in a previous work [32], is clearly identified on the uncoated hydrogel. It 
completely disappears on the sample coated with 2 double layers. In the 1 double layer 
case, only a few pores are still visible. Although 2 double layers seemed to yield a more 
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adequate coating from the point of view of physical homogeneity and drug release 
control, the reduction of the transmittance to 80 % did not allow pursuing this route.  
 
Figure 3 
We then focused our attention on the 1 double layer coating. In order to achieve a 
consistent uniform coating, the crosslinking agent glyoxal, which is a small aldehyde 
known to be biocompatible [51], was added to the chitosan solution. Since the coated 
sample had to be dried at 45 °C, it was not possible to follow the LbL deposition with 
the QCM-D. The wettability, roughness, transmittance, coating thickness and refraction 
index of these new coated samples were determined and are shown in Table 2 (right 
column). This coating has very interesting properties: it is very hydrophilic, even in the 
dry state; it is quite homogeneous (the ellipsometric measurements easily converged in 
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a precise value of thickness); it ensures a transmittance value above 90% which is the 
minimum required for ophthalmic lenses [52,53]; it has a small effect on the bulk 
refraction index of the hydrogel; it should resist to degradation by lysozyme (as 
demonstrated by QCM-D data, in Figure 1, for the coating without glyoxal). The 
contact angle of the hydrated sample, measured with the captive bubble technique, was 
considered to be null due to the bubble instability which derives from the rather 
hydrophilic nature of this surface. The AFM image, shown in Figure 3D, reveals a 
dense coating which completely covers the underlying hydrogel. Thus, the use of this 
type of LbL coating seems to be very promising for drug control release in ophthalmic 
lenses and its effectiveness was tested in different drug/lens systems. 
 
3.2 Drug release profiles of coated ophthalmic hydrogels 
The release profiles of diclofenac, ketorolac, moxifloxacin, and chlorhexidine from 
TRIS/NVP/HEMA coated with 1 double layer (alginate-CaCl2)/(chitosan+glyoxal) 
terminated with alginate-CaCl2 are presented in Figure 4. Comparison of the obtained 
profiles reveals that diclofenac stands out as leading to the most efficient release. 
Apparently, the uptake of diclofenac by the hydrogel is large and reversible yielding a 
cumulative mass release about three times larger than that of the other drugs. In a recent 
study by our group on drug partitioning and diffusion [54], the release of diclofenac and 
chlorhexidine in TRIS/PVP/HEMA were compared. Although both drugs had similar 
partition coefficients, chlorhexidine showed a much stronger adsorption on the 
polymeric fibers than diclofenac which was attributed to the interaction of positively 
charged amine groups with the acrylate groups in the HEMA monomers. Moxifloxacin, 
being lipophilic, should adsorb on the hydrophobic sites of the chains (TRIS 
monomers). The difference between diclofenac and ketorolac is difficult to explain. 
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This means that the uptake and release of diclofenac should be preferentially determined 
by the aqueous phase of the hydrogel and that bulk diffusion essentially determines the 
release profile.  
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Figure 4 
The barrier effect of the LbL coating is clearly most effective for diclofenac. In the case 
of moxifloxacin, the profile was not affected, while for ketorolac and chlorhexidine the 
released amount increased but the rate of release did not improve. Diclofenac is the 
smallest molecule among the studied drugs. Taking into consideration only its size, the 
special efficiency in the release control demonstrated by the LbL coating is unexpected.  
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Several authors proposed the use of chitosan matrices to sustain the release of 
diclofenac from tablets or nanoparticles [55]. Sabnis et al [56] found that, in acidic 
media, the release of diclofenac from chitosan matrices was slowest for chitosan of high 
degree of deacetylation, meaning that the number of amino groups present in the 
polymer backbone is an important factor to control the drug release via (1) the 
formation of a chitosan gel barrier and (2) ionic interactions between ionized amino 
groups and anionic diclofenac. González-Rodríguez et al [57] prepared alginate-
chitosan microspheres for diclofenac release and claimed that drug release was 
controlled by the interactions between diclofenac and the polycation chitosan, in 
competition with alginate. However, other authors claimed that although chitosan 
matrices efficiently entrap diclofenac, the ionic interaction between them is low; in 
other words, the complexes formed between these two molecules should have low 
stability [58,59].The formation of these unstable complexes of chitosan-diclofenac may 
offer an explanation for the retardation effect felt by the diclofenac when crossing the 
surface layer during the release process. There are also reports in the literature on the 
use of chitosan-alginate nanodispersions for ocular sustained delivery of ketorolac but 
the initial burst was not avoided [60]. In our case, the chitosan/alginate based coating 
decreased the initial burst but did not reduce the following release rate. The increase in 
the amount of ketorolac and chlorhexidine released in the presence of the 
chitosan/alginate coating is difficult to explain. One possibility could be a decrease in 
the density of the coating caused by the interaction with the drug. Abruzzo et al [61] 
reported a decrease in the density of chitosan/alginate matrices loaded with 
chlorhexidine, suggesting some extension of the polymeric chains in presence of drug. 
In view of the efficient control of the release of diclofenac achieved with this LbL 
coating on TRIS/NVP/HEMA samples, other substrates were tested. The release 
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profiles of diclofenac from IOL materials (CL26Y and Definitive 50), shown in Figures 
5A and 5B, respectively,  reveal that the amount of drug released is much higher for the 
more hydrophobic silicone-based Definitive 50 hydrogel (Figure 5B). Furthermore, 
comparison of the IOL materials with the TRIS/NVP/HEMA (Figure 4A) confirms that 
the diclofenac release is directly correlated with the water content of the hydrogel which 
is minimum for CL26Y. The barrier effect of the LbL coating exists for both IOL 
materials but it is more striking in the case of Definitive 50, where the initial release rate 
is considerably reduced and the release duration increased, at least, up to 120 h. 
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Figure 5 
Although, further tests are needed to confirm the feasibility of using these alginate-
chitosan based LbL coatings on ophthalmic materials, namely their mechanical 
properties, resistance to blinking and cytocompatibility, our study suggests that they 
may offer a valuable solution to control the release of diclofenac from different lens 
materials. Besides their ability to avoid the initial burst, typical of drug loaded lenses, 
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these coatings increase dramatically the hydrophilicity of the silicone-based material, 
thus avoiding extra surface treatments usually performed to ensure high comfort to lens 
wearers and to minimize deposits of lipids and proteins from the tear fluid.  The barrier 
effect of the coating seems to be independent of the size of the drug molecule, but it is 
strongly determined by its chemical nature. The coating was not efficient for the control 
of the release of the other studied drugs, even the anionic ketorolac.  At this point, we 
are not able to give a reasonable explanation for the different behaviours. However, in 
view of the promising results obtained with diclofenac, it would be important to pursue 
with this investigation, looking for other types of functionalized chitosan and/or 
crosslinking agents in order to optimize the reversible interactions between drug and 
coating needed to ensure a sustained release.   
 
4. Conclusions 
 
This work describes an investigation about the use of coatings obtained with the LbL 
deposition of alginate/chitosan-based layers to control the drug release from ophthalmic 
lens materials. Optimization of the properties of the coated samples taking into 
consideration the requirements for their application as ophthalmic lens materials was 
first attempted using TRIS/NVP/HEMA hydrogel and diclofenac. Very good results 
were obtained with the double layer (alginate-CaCl2)/(chitosan+glyoxal) topped with a 
final alginate-CaCl2 layer to avoid chitosan degradation by tear fluid proteins. The 
coating is dense, homogeneous, and very hydrophilic; it does not affect the bulk 
refraction index, slightly reduces the light transmittance and leads to a controlled release 
of diclofenac for more than one week. Such a promising behaviour led us to investigate 
its performance with other drugs (ketorolac, moxifloxacin and chlorhexidine) and two 
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IOL materials (CI26Y and Definitive 50). The barrier effect of the coating revealed to 
be strongly affected by the characteristics of the pair hydrogel/drug: it existed for the 
three tested hydrogels but was more prominent for TRIS/NVP/HEMA; surprisingly, 
only diclofenac, which is the smallest molecule, was effectively controlled. Further 
studies using adequately functionalized chitosan should be done to optimize the release 
control of each specific drug. 
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Figure Captions 
 
Figure 1. Normalized shift in the frequency, ∆f/n, (dark grey line) and shift in the 
dissipation, ∆D,  (light grey line) for the third harmonic of the resonant frequency of a 
quartz crystal sensor after being coated with a TRIS/NVP/HEMA hydrogel film, during 
successive additions of solutions of PEI (1), rising with DD water (2) alginate (3), 
CaCl2 (4), chitosan (5), rising with NaCl (6) and lysozyme (7) as a function of the time, 
to form a double layer of (alginate- CaCl2) / chitosan topped with a final layer of 
alginate-CaCl2. 
 
Figure 2. Cumulative release profiles of diclofenac from TRIS/NVP/HEMA hydrogels 
uncoated (○), and coated with 1 ( ), 2 (♦) and 4 (▲) (alginate-CaCl2)/chitosan double 
layers, terminated by an alginate-CaCl2 final layer. The error bars are  ±  the standard 
deviations (n=7). The uncoated hydrogels (blank samples) are different from those 
presented  
 
Figure 3. AFM images of the surface of TRIS/NVP/HEMA: uncoated (A); coated with 
1 double layer (B); coated with 2 double layers (C); coated with 1 double layer 
containing glyoxal (D). 
 
Figure 4. Cumulative mass release of diclofenac (A), ketorolac (B), moxifloxacin (C), 
and chlorhexidine (D) from TRIS/NVP/HEMA coated with 1 double layer of (alginate- 
CaCl2)/(chitosan+glyoxal) terminated with alginate-CaCl2 (closed symbols).The open 
symbols refer to the drug release from uncoated lenses. The error bars are  ±  the 
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standard deviations (n=7).The inserts represent the release data obtained during the first 
24 hours. 
 
Figure 5. Cumulative mass release of diclofenac from CI26Y (A) and Definitive 50 (B) 
coated with 1 double layer of (alginate-CaCl2)/(chitosan+glyoxal) terminated with 
alginate-CaCl2 (closed symbols).The open symbols refer to the drug release from 
uncoated lenses  (blank samples). The error bars are  ±  the standard deviations: A 
(n=6), B (n=7). The inserts represent the release data obtained during the first 24 hours. 
 
 
